The target genes of HSF1 in the steps of NAFLD disease progression involve chaperones, such as heat shock proteins [13,26], PPARgamma coactivator-1alpha [14,24], and the CaM-Akt pathway [22]. This evidence concerns the gene AKT1 and metabolic dysfunction-associated steatotic liver disease.